Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?

Multimodal treatment is currently the standard of care for locally advanced esophagogastric junction (EGJ) adenocarcinoma due to poor results after surgery alone. Neoadjuvant therapy is intended to shrink the tumor and eliminate potential circulating tumor cells. However, which neoadjuvant treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Laxague, Francisco, Schlottmann, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317651/
https://www.ncbi.nlm.nih.gov/pubmed/34367928
http://dx.doi.org/10.5306/wjco.v12.i7.557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317651/
https://www.ncbi.nlm.nih.gov/pubmed/34367928
http://dx.doi.org/10.5306/wjco.v12.i7.557

Ejemplares similares